SOURCE: Parenteral Drug Association (PDA)

January 17, 2008 16:18 ET

PDA Announces Opportunity for Open Discussion; EU GMP Annex 2 - Manufacture of Biological Medicinal Products for Human Use

BETHESDA, MD--(Marketwire - January 17, 2008) - The Parenteral Drug Association (PDA) [http://www.pda.org] today announced that it is arranging a public meeting for the European Medicines Agency (EMEA) to discuss Draft Annex 2: Manufacture of Biological Products for Human Use. The open meeting will take place February 19, 2008 in Budapest, Hungary, one day prior to the PDA/EMEA Joint Conference.

Interested parties are encouraged to comment on the draft guidance and to attend the public meeting. Specifics on the session, instructions for making comments and registration for the public meeting and the PDA/EMEA Joint Conference are available at www.pda.org.

About PDA

Connecting People, Science and Regulation®

The Parenteral Drug Association (PDA) is a nonprofit international organization and a leading global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community. PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 10,000 members worldwide. More information about PDA is available at www.pda.org.

Contact Information

  • Contact:
    Diana Kaminsky
    Email Contact
    Tel: +1 (301) 656-5900, ext. 145